NEW Amsterdam Sciences
Scottsdale, US · Founded 2012 · Delaware corporation
Founders & leadership
MK
Michael K. WilhelmExecutive
JT
Jerry ToepferExecutive
HN
Hal N. Siegel, PhD.Executive
Reported raises · per SEC filings
Form D private placements$250K disclosed across 1 round · 2015
▶$250KraisedNov 2015 · 3 investors · BiotechnologyRule 506(b)
▶$250KraisedNov 2015 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael K. WilhelmExecutive Officer
- Jerry ToepferExecutive Officer
- Hal N. Siegel, PhD.Executive Officer
- Offering amount
- $2M
- Amount sold
- $250K
- Minimum investment
- $50K
- First sale
- Oct 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has NEW Amsterdam Sciences raised?
- NEW Amsterdam Sciences has disclosed $250K raised across 1 round.
- Where is NEW Amsterdam Sciences headquartered?
- NEW Amsterdam Sciences is headquartered in Scottsdale, US.